Corporate Governance19 Jun 2026, 11:37 am
ANG Lifesciences Closes Trading Window for Q1 FY27 Results
AI Summary
ANG Lifesciences India Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The company has advised all designated persons and their immediate relatives not to trade in its securities during this period, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The date of the board meeting to consider these financial results will be intimated separately.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is until 48 hours post Q1 FY27 results declaration.
- Applies to insiders, designated persons, and relatives.
- Aims to comply with SEBI Insider Trading Regulations.
- Board meeting date for results to be announced later.
Price Impact
More from ANG